Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

8.7%

2 terminated out of 23 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

13%

3 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed with results

Key Signals

1 with results80% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (10)
Early P 1 (1)
P 1 (1)
P 2 (1)
P 3 (1)
P 4 (2)

Trial Status

Completed8
Recruiting8
Unknown3
Enrolling By Invitation2
Terminated2

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT07537127Not ApplicableRecruitingPrimary

Lidocaine for LESS Postoperative Shoulder Pain Alleviation

NCT06996561Phase 2Recruiting

Exploring the Impact of Genetic Variations on The Clinical Efficacy of Nalbuphine in Postoperative Pain Management

NCT07225205Not ApplicableRecruiting

Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy

NCT07148765Not ApplicableEnrolling By Invitation

Use of Wearables Following Cystectomy- Part II

NCT07008261Recruiting

Robot-assisted Cystectomies With Regard to Blood Loss, Pain and Transfusions.

NCT07091565Enrolling By Invitation

Supporting Sexual Recovery in Women With Bladder Cancer

NCT07043790Not ApplicableCompleted

Radical Cystectomy Versus Tri-Modal Therapy for Treatment of cT2N0M0 Urinary Bladder Transitional Cell Carcinoma

NCT06002269Not ApplicableCompleted

A Home-based Lifestyle Intervention for Optimizing Surgical Outcomes Among Urinary Bladder Cancer Patients

NCT04300231Phase 3CompletedPrimary

Thoracic Epidural Analgesia Versus Rectus Sheath Block Versus Surgeon Infiltration With Liposomal Bupivacaine or Standard Bupivacaine for Post-Operative Pain Control After Cystectomy

NCT06770530Phase 4RecruitingPrimary

Introduction of Mycotic Prophylaxis At Cystectomy Trial.

NCT06709196Phase 4RecruitingPrimary

Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis

NCT04118712Recruiting

Pediatric Ovarian Tissue Banking - Operative Specimens From Females 0-18 Years of Age

NCT03500744Not ApplicableTerminated

Erector Spinae Plane Block for Major Gynecologic and Urologic Surgery

NCT05715684Not ApplicableRecruiting

Patient-Centered Surgical Prehabilitation

NCT05037552Not ApplicableUnknown

Benefit of Hemostatic Sealant in Preservation of Ovarian Reserve

NCT04028934Completed

Study of the Quality of Life of Patients Treated by Heavy Surgery as Part of an Enhanced Recovery at Beau Soleil Clinic- QUALICHIR

NCT02665156Not ApplicableCompletedPrimary

Time Efficiency of Intracorporeal Orthotopic Diversion With Robotic Staplers After Robot Assisted Radical Cystectomy

NCT03280459Unknown

Evaluation of Robot-assisted Intracorporeal Urinary Reconstruction

NCT02238886Not ApplicableCompleted

Radical Cystectomy, Nutrition and Convalescence

NCT01245660Early Phase 1Terminated

A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before Cystectomy

Scroll to load more

Research Network

Activity Timeline